Menu
Brazil
home Table of contents navigate_before previous current next navigate_next
home Table of contents
Relatos de Casos • Arq. Bras. Oftalmol. 68 (4) • Aug 2005 • https://doi.org/10.1590/S0004-27492005000400027 linkcopy

Open-access Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in central serous chorioretinopathy: case report

AuthorshipSCIMAGO INSTITUTIONS RANKINGS

    We report the use of photodynamic therapy with verteporfin for subfoveal choroidal neovacularization in central serous chorioretinopathy. Visual acuity improved (0.5 to 1.0) 30 days after the first session. After 141 days, the choroidal neovascularization reactivated and the patient was retreated. Again, visual acuity improved (0.5 to 1.0) 30 days afterwards. It remains stable after 20 months. Photodynamic therapy can be efficient in the treatment of choroidal neovascularization in central serous chorioretinopathy.

    Choroid diseases; Choroidal neovascularization; Choroidal neovascularization; Retinal diseases; Retinal detachment; Photochemotherapy; Photosensitizing agents; Porphyrins

    vertical_align_top file_download show_chart
    location_on
    Conselho Brasileiro de Oftalmologia Rua Casa do Ator, 1117 - cj.21, 04546-004 São Paulo SP Brazil, Tel: 55 11 - 3266-4000, Fax: 55 11- 3171-0953 - São Paulo - SP - Brazil
    E-mail: abo@cbo.com.br
    rss_feed Stay informed of issues for this journal through your RSS reader
    Accessibility / Report Error